Author Archives: Jan Paschal

The IPO Calendar is light this week as Wall Street celebrates Donald Trump’s victory in the U.S. presidential election, as Bloomberg reported. The Dow Jones Industrial Average jumped more than 1,000 points at the opening today – following through on the forecast from U.S. stock futures, which had rocketed higher while U.S. Treasury bond yields jumped. […]

Two SPAC IPOs- Bleichroeder Acquisition Corp. I and Newbury Street Acquisition II Corp. – raised $400 million combined at pricing on Halloween night, Thursday, Oct. 31, 2024: –Bleichroeder Acquisition Corp. I (BACQU) priced 25.0 million units at $10.00 each to raise $250.0 million. Cohen & Company Capital Markets and Seaport Global were the joint book-runners. Each […]

Gelteq Ltd. (GELS) priced its tiny IPO of 1.3 million shares at $4.00 – the terms in the prospectus – to raise $5.2 million on Monday night, Oct. 28, 2024. Gelteq’s stock started trading Tuesday, Oct. 29, 2024 – opening flat at $4.00 at 10:49 a.m. EDT on the NASDAQ on volume of 278,543 shares. (Editor’s Note: […]

WeRide (WRD) of China upsized its IPO at pricing to 7.74 million American Depositary Shares – up from 6.45 million ADS in the prospectus – and priced the IPO at $15.50 – the low end of its $15.50-to-$18.50 price range – to raise $120.01 million on Thursday night, Oct. 24, 2024. WeRide’s ADS opened flat at $15.50 […]

Septerna Inc. (SEPN), a thyroid-focused Phase I biotech, upsized its IPO at pricing to 16.0 million shares – up from 15.28 million shares in the recently upsized prospectus – and priced the IPO at $18.00 – as planned – to raise $288.0 million on Thursday night, Oct. 24, 2024. Septerna’s stock opened at $23.50 – up […]

Septerna Inc. (SEPN Proposed), a Phase 1 biotech focused on developing drugs to treat thyroid and autoimmune disorders, increased its IPO’s size by 57 percent to raise $275 million – up from $175 million originally – in an S-1/A filing early today – Thursday, Oct. 24, 2024. The new terms of Septerna’s IPO are: 15.28 million […]

Ingram Micro Holding Corp. (INGM) priced its IPO at $22.00  – $1.00 below the top of its $20.00-to-$23.00 price range – and sold the full 18.6 million shares – the number of shares in the prospectus – to raise $409.2 million on Wednesday night, Oct. 23, 2024. Ingram Micro’s stock is expected to start trading on Thursday, Oct. 24, […]

Aldel Financial II (ALDFU) priced its SPAC IPO in sync with the terms in the prospectus – 20.0 million units at  $10.00 each – to raise $200.0 million on Monday night, Oct. 21, 2024. Each unit consists of one ordinary share and one-half of one redeemable warrant. Shares of Aldel Financial II are expected to […]

China’s HUHUTECH International (HUHU) cuts its IPO at pricing to 1.05 million shares –  down from 1.25 million shares in the prospectus – and priced the deal at $4.00  – the low end of its $4.00-to-$6.00 price range – to raise $4.2 million on Monday night, Oct. 21, 2024. HUHUTECH International’s stock opened flat – at […]

Septerna Inc. (SEPN Proposed), a Phase 1 biotech focused on developing an oral drug to treat hypoparathyroidism, a rare endocrine disease, unveiled the terms for its $175 million IPO early today – Monday, Oct. 21, 2024. Septerna is offering 10.94 million shares at a price range of $15.00 to $17.00 to raise $175.0 million,  if […]